Former Irish President Mary Robinson To Chair LIVESTRONG(TM) Global Cancer Summit

The Lance Armstrong Foundation (LAF) announced that Mary Robinson, the first female President of Ireland and former United Nations High Commissioner for Human Rights, will serve as Honorary Chairperson of the LIVESTRONG Global Cancer Summit. The Summit, to be held in Dublin, Ireland August 24-26, 2009, is the landmark event of the LIVESTRONG Global Cancer […]

Pioneering Cancer Prevention Program Launched In New York

A prevention program serving an ethnically diverse population of women at high risk of cancer is detailed in an article published Monday 23 March in the online peer-reviewed journal ecancer. The article describes a screening program to identify women from underserved communities who are at a high risk of developing breast or ovarian cancer; a […]

Hollow Gold Nanospheres Show Promise For Biomedical And Other Applications

A new metal nanostructure developed by researchers at the University of California, Santa Cruz, has already shown promise in cancer therapy studies and could be used for chemical and biological sensors and other applications as well. The hollow gold nanospheres developed in the laboratory of Jin Zhang, a professor of chemistry and biochemistry at UCSC, […]

Latest Data On UK Cancer Survival Fuel Debate Over Effectiveness Of NHS Cancer Plan For England

The National Health Service (NHS) cancer plan for England shows some beneficial effect on survival, although wide regional variations remain; more follow-up data are needed before the true impact of the cancer plan can be fully established. These are the conclusions of the first study to assess whether the cancer plan is working, published in […]

Anthracycline-­Induced Cardiotoxicity: Risk Assessment and Management

In the current issue of ONCOLOGY, Hershman and Shao provide a comprehensive review of anthracycline-induced cardiotoxicity (AIC). Risk factors for AIC include age (??18 or ??65 years) at time of treatment, increasing cumulative dose or dose intensity of anthracyclines, mediastinal radiation therapy (RT), and female gender.[1-4] The Surveillance, Epidemiology and End Results (SEER)-Medicare database showed […]

The Challenges of Improving Breast Cancer Outcome With Diagnostic Imaging Techniques

Positron-emission tomography (PET) technology has drastically improved in the past few years, with the development of hybrid imaging devices combining PET and computed tomography (CT), which have essentially replaced stand-alone PET scanners in most centers. Image quality has also increased with the use of improved PET detectors and image reconstruction techniques. While a few years […]

ARIMIDEX Offers Women Greater Protection Against HR+ Early Breast Cancer Returning In The 1st 2 Yrs

“Anastrozole is the only aromatase inhibitor (AI) which has now been shown to prevent recurrences in women with hormone receptor positive early breast cancer both during the initial high-risk two years after surgery, and also well beyond the completion of treatment. In breast cancer there are no guarantees and we can’t predict which women will […]

Women With Early Breast Cancer To Receive The Most Up-to-date Information Available, Australia

National Breast and Ovarian Cancer Centre (NBOCC) has now released the eagerly anticipated revised version of its Guide for women with early breast cancer. The comprehensive, 200 page resource provides information to support women with early breast cancer* in making decisions about their treatment and care, as well as advice for family and friends. The […]

Cephalon Response To NICE Guidance On Advanced Breast Cancer Treatment Published 25 February 2009, UK

Liz Hardaker, medical director of Cephalon UK. “We are disappointed and surprised that NICE has not taken this opportunity to distinguish between different forms of anthracycline treatment; specifically the use of liposomal-encapsulated doxorubicin. “Myocet, in combination with cyclophosphamide, is indicated for the first line treatment of metastatic breast cancer in women (SmPC). A number of […]

Systematic Estimation Of Breast Cancer Risk Appears Justified In Postmenopausal Women

Screening for breast cancer risk in all postmenopausal women, using a combination of risk factors and breast density, can identify women at high risk of disease, according to systematic literature reviews and meta-analyses reported in the March 10 online issue of the Journal of the National Cancer Institute. The reviews and meta-analyses also support the […]